Race against dementia: Join the drive to eradicate the disease

Written by

Dementia is the umbrella term for a wide range of conditions that affect the brain and cause symptoms such as memory loss, cognitive impairment, and impaired decision-making. More than 55 million people live with dementia globally; the most common form is Alzheimer’s disease. Currently, there is no cure – only treatment to slow the progression of symptoms. A charity founded […]

Neuropathological changes in Alzheimer’s disease linked to four key proteins

Written by

Professor Rafael Luján explores the neuropathological alterations in Alzheimer's disease through analysis of four key proteins in AD that affect the ability of nerve cells to process and transmit signals.

Alzheimer’s disease (AD) is characterised by progressive and irreversible loss of memory and thinking skills. Using sensitive cutting-edge techniques, Professor Rafael Luján and his collaborators at Castilla-La Mancha University, Spain, have found changes in the number, distribution, and density of four key proteins in AD. Notably, these proteins affect the ability of nerve cells to process and transmit signals. Not […]

Dihydromyricetin shows promise as anxiety disorder treatment

Written by

Jing Liang discovered that dihydromyricetin could have potential as a new treatment for anxiety disorders.

Anxiety disorders are one of the most common mental illnesses, and social isolation can be a major source of contributing stress. Medications to treat these disorders, such as benzodiazepines, are available; however, they come with a range of downsides. In a recent study in mice, Prof Jing Liang’s team at the USC School of Pharmacy in the US discovered that […]